Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004323 | 1.00 | MEN1 (0.47) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2268617 | 1.00 | MEN1 (0.47) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL8526542 | 0.91 | MEN1 (0.40) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL29521447 | 0.88 | TSHR (0.54) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL7934390 | 0.88 | TSHR (0.54) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL5898720 | 0.88 | TSHR (0.54) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL29521561 | 0.88 | TSHR (0.54) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1003837 | 0.87 | — | — | |
| SCHEMBL13771050 | 0.87 | — | — | |
| SCHEMBL29521238 | 0.86 | MEN1 (0.57) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116068853-A | Photosensitive resin composition and display device | 三星显示有限公司 | 2023-05-05 | — | — | CN | claimed |
| US-11597851-B2 | Ink for screen printing | DAICEL CORPORATION (JP) | 2023-03-07 | — | — | US | claimed |
| CN-110400932-B | Electrochemical cell and preparation method thereof | 国轩高科美国研究院 | 2022-06-28 | — | — | CN | claimed |
| CN-105368611-B | Cleaning compositions | 东友精细化工有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-206746057-U | For producing the settling tank of diethylene glycol methyl-n-butyl ether | 安徽立兴化工有限公司 | 2017-12-15 | — | — | CN | claimed |
| EP-2937918-A1 | HINDERED GLYMES FOR ELECTROLYTE COMPOSITIONS | CIC Energigune (ES) | 2015-10-28 | — | — | EP | claimed |
| EP-2287441-A2 | Oil and gas field chemicals | INEOS EUROPE LIMITED (GB) | 2011-02-23 | — | — | EP | claimed |
| US-20030150779-A1 | Process for removing metal ions from crude oil | BP EXPLORATION OPERATING COMPANY LIMITED (GB) | 2003-08-14 | — | — | US | claimed |
| EP-1294827-A1 | PROCESS FOR REMOVING METAL IONS FROM CRUDE OIL | BP EXPLORATION OPERATING COMPANY LIMITED (GB) | 2003-03-26 | — | — | EP | claimed |
| WO-2001092439-A1 | PROCESS FOR REMOVING METAL IONS FROM CRUDE OIL | BP EXPLORATION OPERATING COMPANY LIMITED (GB) | 2001-12-06 | — | — | WO | claimed |
| EP-0886718-B1 | OIL AND GAS FIELD CHEMICALS | BP CHEM INT LTD (GB) | 2001-11-28 | — | — | EP | claimed |
| US-6173780-B1 | Process for increasing effectiveness of production chemicals by reducing number of squeezing and shut-in operations required to increase production rate from an oil well | BP CHEMICALS LIMITED (GB) | 2001-01-16 | — | — | US | claimed |
| US-6148913-A | MINIMIZING OPERATIONS NEEDED TO INHIBIT SCALE IN OIL WELLS, BY INJECTING A WATER MISCIBLE GLYCOL ETHER SURFACTANT, A WATER SOLUBLE METAL SALT OF MULTIVALENT CATION, AND AN ANIONIC COMPOUND WHICH FORMS AN ANTISCALE PRECIPITATE IN SITU | BP CHEMICALS LIMITED (GB) | 2000-11-21 | — | — | US | claimed |
| EP-0886719-A1 | A PROCESS AND A FORMULATION TO INHIBIT SCALE IN OIL FIELD PRODUCTION | BP Chemicals Limited (GB) | 1998-12-30 | — | — | EP | claimed |
| WO-1998030783-A1 | A PROCESS AND A FORMULATION TO INHIBIT SCALE IN OIL FIELD PRODUCTION | BP CHEMICALS LIMITED (GB) | 1998-07-16 | — | — | WO | claimed |
| US-12624242-B2 | Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method | SEIKO EPSON CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | DAICEL CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| WO-1998002636-A1 | USE OF OIL AND GAS FIELD CHEMICALS | BP CHEMICALS LIMITED (GB) | 1998-01-22 | — | — | WO | disclosed |
| US-4299751-A | Cold-setting, polyurethane-based molding material binder | HUTTENES-ALBERTUS CHEMISCHE WERKE GMBH (DE) | 1981-11-10 | — | — | US | disclosed |
| US-4255571-A | Catalytic dehydrogenation preparation of 3-pyridazones | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624242-B2 | Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method | HAO2, PHOSPHO1, HAO1 | MEN1 2240/4885KMT2A 3610/4885THRB 341/4885 |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | MARK3, OR10J3, ILK | MEN1 3920/4885KMT2A 3162/4885THRB 2828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.